Asahi India Glass Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 22, 2025, 8:00 am

Competitors of Asahi India Glass Ltd

All Competitor Stocks of Asahi India Glass Ltd

Quarterly Result

Last Updated: August 2, 2025, 12:05 am

Below is a detailed analysis of the quarterly data for Asahi India Glass Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 1,229.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,180.00 Cr. (Mar 2025) to 1,229.00 Cr., marking an increase of 49.00 Cr..
• For Expenses, as of Jun 2025, the value is 1,036.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 983.00 Cr. (Mar 2025) to 1,036.00 Cr., marking an increase of 53.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 192.00 Cr.. The value appears to be declining and may need further review. It has decreased from 197.00 Cr. (Mar 2025) to 192.00 Cr., marking a decrease of 5.00 Cr..
• For OPM %, as of Jun 2025, the value is 16.00%. The value appears to be declining and may need further review. It has decreased from 17.00% (Mar 2025) to 16.00%, marking a decrease of 1.00%.
• For Other Income, as of Jun 2025, the value is 11.00 Cr.. The value appears strong and on an upward trend. It has increased from 9.00 Cr. (Mar 2025) to 11.00 Cr., marking an increase of 2.00 Cr..
• For Interest, as of Jun 2025, the value is 59.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 33.00 Cr. (Mar 2025) to 59.00 Cr., marking an increase of 26.00 Cr..
• For Depreciation, as of Jun 2025, the value is 68.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 49.00 Cr. (Mar 2025) to 68.00 Cr., marking an increase of 19.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 76.00 Cr.. The value appears to be declining and may need further review. It has decreased from 124.00 Cr. (Mar 2025) to 76.00 Cr., marking a decrease of 48.00 Cr..
• For Tax %, as of Jun 2025, the value is 28.00%. The value appears to be increasing, which may not be favorable. It has increased from 26.00% (Mar 2025) to 28.00%, marking an increase of 2.00%.
• For Net Profit, as of Jun 2025, the value is 55.00 Cr.. The value appears to be declining and may need further review. It has decreased from 92.00 Cr. (Mar 2025) to 55.00 Cr., marking a decrease of 37.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 2.31. The value appears to be declining and may need further review. It has decreased from 3.80 (Mar 2025) to 2.31, marking a decrease of 1.49.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 5:44 am

Growth

Last Updated: September 4, 2025, 11:40 pm

Balance Sheet

Last Updated: November 9, 2025, 1:40 pm

Below is a detailed analysis of the balance sheet data for Asahi India Glass Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 25.00 Cr.. The value appears strong and on an upward trend. It has increased from 24.00 Cr. (Mar 2025) to 25.00 Cr., marking an increase of 1.00 Cr..
• For Reserves, as of Sep 2025, the value is 3,675.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,645.00 Cr. (Mar 2025) to 3,675.00 Cr., marking an increase of 1,030.00 Cr..
• For Borrowings, as of Sep 2025, the value is 2,856.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 2,696.00 Cr. (Mar 2025) to 2,856.00 Cr., marking an increase of 160.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 1,345.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,425.00 Cr. (Mar 2025) to 1,345.00 Cr., marking a decrease of 80.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 7,902.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6,790.00 Cr. (Mar 2025) to 7,902.00 Cr., marking an increase of 1,112.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 3,984.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4,046.00 Cr. (Mar 2025) to 3,984.00 Cr., marking a decrease of 62.00 Cr..
• For CWIP, as of Sep 2025, the value is 848.00 Cr.. The value appears strong and on an upward trend. It has increased from 562.00 Cr. (Mar 2025) to 848.00 Cr., marking an increase of 286.00 Cr..
• For Investments, as of Sep 2025, the value is 52.00 Cr.. The value appears strong and on an upward trend. It has increased from 50.00 Cr. (Mar 2025) to 52.00 Cr., marking an increase of 2.00 Cr..
• For Other Assets, as of Sep 2025, the value is 3,019.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,132.00 Cr. (Mar 2025) to 3,019.00 Cr., marking an increase of 887.00 Cr..
• For Total Assets, as of Sep 2025, the value is 7,902.00 Cr.. The value appears strong and on an upward trend. It has increased from 6,790.00 Cr. (Mar 2025) to 7,902.00 Cr., marking an increase of 1,112.00 Cr..

Notably, the Reserves (3,675.00 Cr.) exceed the Borrowings (2,856.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Asahi India Glass Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 15.27. This value is within the healthy range. It has increased from 13.49 (Mar 24) to 15.27, marking an increase of 1.78.
• For Diluted EPS (Rs.), as of Mar 25, the value is 15.27. This value is within the healthy range. It has increased from 13.49 (Mar 24) to 15.27, marking an increase of 1.78.
• For Cash EPS (Rs.), as of Mar 25, the value is 22.88. This value is within the healthy range. It has increased from 20.31 (Mar 24) to 22.88, marking an increase of 2.57.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 109.79. It has increased from 95.88 (Mar 24) to 109.79, marking an increase of 13.91.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 109.79. It has increased from 95.88 (Mar 24) to 109.79, marking an increase of 13.91.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 189.00. It has increased from 178.55 (Mar 24) to 189.00, marking an increase of 10.45.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 32.83. This value is within the healthy range. It has increased from 30.74 (Mar 24) to 32.83, marking an increase of 2.09.
• For PBIT / Share (Rs.), as of Mar 25, the value is 24.95. This value is within the healthy range. It has increased from 23.46 (Mar 24) to 24.95, marking an increase of 1.49.
• For PBT / Share (Rs.), as of Mar 25, the value is 20.98. This value is within the healthy range. It has increased from 17.87 (Mar 24) to 20.98, marking an increase of 3.11.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 15.00. This value is within the healthy range. It has increased from 13.04 (Mar 24) to 15.00, marking an increase of 1.96.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 15.27. This value is within the healthy range. It has increased from 13.49 (Mar 24) to 15.27, marking an increase of 1.78.
• For PBDIT Margin (%), as of Mar 25, the value is 17.37. This value is within the healthy range. It has increased from 17.21 (Mar 24) to 17.37, marking an increase of 0.16.
• For PBIT Margin (%), as of Mar 25, the value is 13.20. This value is within the healthy range. It has increased from 13.14 (Mar 24) to 13.20, marking an increase of 0.06.
• For PBT Margin (%), as of Mar 25, the value is 11.10. This value is within the healthy range. It has increased from 10.00 (Mar 24) to 11.10, marking an increase of 1.10.
• For Net Profit Margin (%), as of Mar 25, the value is 7.93. This value is within the healthy range. It has increased from 7.30 (Mar 24) to 7.93, marking an increase of 0.63.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 8.08. This value is within the healthy range. It has increased from 7.55 (Mar 24) to 8.08, marking an increase of 0.53.
• For Return on Networth / Equity (%), as of Mar 25, the value is 13.91. This value is below the healthy minimum of 15. It has decreased from 13.93 (Mar 24) to 13.91, marking a decrease of 0.02.
• For Return on Capital Employeed (%), as of Mar 25, the value is 12.32. This value is within the healthy range. It has decreased from 14.98 (Mar 24) to 12.32, marking a decrease of 2.66.
• For Return On Assets (%), as of Mar 25, the value is 5.46. This value is within the healthy range. It has decreased from 5.96 (Mar 24) to 5.46, marking a decrease of 0.50.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.73. This value is within the healthy range. It has increased from 0.54 (Mar 24) to 0.73, marking an increase of 0.19.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.94. This value is within the healthy range. It has increased from 0.79 (Mar 24) to 0.94, marking an increase of 0.15.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.74. It has decreased from 0.86 (Mar 24) to 0.74, marking a decrease of 0.12.
• For Current Ratio (X), as of Mar 25, the value is 1.08. This value is below the healthy minimum of 1.5. It has increased from 1.03 (Mar 24) to 1.08, marking an increase of 0.05.
• For Quick Ratio (X), as of Mar 25, the value is 0.48. This value is below the healthy minimum of 1. It has increased from 0.44 (Mar 24) to 0.48, marking an increase of 0.04.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.57. This value is below the healthy minimum of 4. It has increased from 1.55 (Mar 24) to 1.57, marking an increase of 0.02.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 14.82 (Mar 24) to 0.00, marking a decrease of 14.82.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 9.63 (Mar 24) to 0.00, marking a decrease of 9.63.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 85.18 (Mar 24) to 0.00, marking a decrease of 85.18.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 90.37 (Mar 24) to 0.00, marking a decrease of 90.37.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 6.22. This value is within the healthy range. It has increased from 5.50 (Mar 24) to 6.22, marking an increase of 0.72.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.59. This value is within the healthy range. It has increased from 3.33 (Mar 24) to 3.59, marking an increase of 0.26.
• For Enterprise Value (Cr.), as of Mar 25, the value is 16,978.79. It has increased from 14,685.54 (Mar 24) to 16,978.79, marking an increase of 2,293.25.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.70. This value exceeds the healthy maximum of 3. It has increased from 3.38 (Mar 24) to 3.70, marking an increase of 0.32.
• For EV / EBITDA (X), as of Mar 25, the value is 21.27. This value exceeds the healthy maximum of 15. It has increased from 19.65 (Mar 24) to 21.27, marking an increase of 1.62.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.19. This value exceeds the healthy maximum of 3. It has increased from 3.00 (Mar 24) to 3.19, marking an increase of 0.19.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 85.17 (Mar 24) to 0.00, marking a decrease of 85.17.
• For Price / BV (X), as of Mar 25, the value is 5.49. This value exceeds the healthy maximum of 3. It has decreased from 5.53 (Mar 24) to 5.49, marking a decrease of 0.04.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.19. This value exceeds the healthy maximum of 3. It has increased from 3.00 (Mar 24) to 3.19, marking an increase of 0.19.
• For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness